2021 News

Blueberry Therapeutics secures further investment

NPIF – Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the Northern Powerhouse Investment Fund (“NPIF”) has invested £750,000 in Blueberry Therapeutics Limited (“Blueberry&r...

Infex Therapeutics partners with Alderley Analytical

Alderley Park, Cheshire Infex Therapeutics has today announced a deal with Alderley Analytical, to support PK and ADA analysis of Infex’s RESP-X program. RESP-X is an anti-virulence therapy in-licensed from Japanese pharma compan...

INFEX Therapeutics appoints Lonza to manufacture new lung infection drug

Alderley Park, Cheshire - Infex Therapeutics has awarded a £1m contract to Lonza to help progress its RESP-X program, a novel therapy which targets serious recurrent respiratory infections in patients with damaged lung functions. ...

From our portfolio



viewview our portfolio

Our Team

Nick Wright


view complete team

Contact us

Tel: 01625 344300